Healthcare costs of patients with cancer stratified by Khorana score risk levels.
Alok A KhoranaNicole M KudererKeith McCraeDejan MilentijevicGuillaume GermainFrançois LalibertéSean D MacKnightPatrick LefebvreGary H LymanMichael B StreiffPublished in: Journal of medical economics (2021)
This real-world analysis found that cancer patients at higher risk of VTE (based on KS) incurred significantly greater all-cause and VTE-related healthcare costs compared with cancer patients at lower risk of VTE.